SOLVED5357

An oncology patient is to begin treatment for non-small-cell lung cancer (NSCLC) with administration of gefitinib. The nurse notes on the medical record that the patient is also taking warfarin daily for atrial fibrillation. Which statement indicates the nurse is aware of genfitinib’s mechanism of action? Group of answer choices Gefitinib may reach toxic levels when given concurrently with warfarin. Increases the effects of warfarin. Gefitinib should not be given to a patient taking anticoagulants. May require a dose increase when taken with warfarin.
SCIENCE
HEALTH SCIENCE
NURSING

******CLICK ORDER NOW BELOW AND OUR WRITERS WILL WRITE AN ANSWER TO THIS ASSIGNMENT OR ANY OTHER ASSIGNMENT, DISCUSSION, ESSAY, HOMEWORK OR QUESTION YOU MAY HAVE. OUR PAPERS ARE PLAGIARISM FREE*******."